FCM
BCLI

Fourpath Capital Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Fourpath Capital Management’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-69
Closed -$238 – 283
2024
Q3 		$238 Buy
+69
New +$238 ﹤0.01% 753